PPARD and Hepatic fibrosis: However, telmisartan also induces anti-fibrotic and anti-obesity effects through PPARδ-dependent pathways37,38 and enacts anti-hepatic fibrosis and anti-dyslipidemic effects through PPARα-dependent pathways4,39.